Hon CHRIS HIPKINS: One of the things that's better understood is around the efficacy of the measles vaccine; we know a bit more about what we're dealing with there. We know more around what's required to get herd immunity with the measles vaccination campaign. We don't yet know all of that information around COVID-19.